Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer
Journal of Basic and Clinical Health Sciences · 31.05.2026 · 10 (2) · 222-228
DOI: 10.30621/jbachs.1834209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Clinical Health Sciences, online erschienen am 31.05.2026. Verfasst von Faruk Recep Özalp und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Metastatic hormone-sensitive prostate cancer (mHSPC) requires accessible biomarkers for better prognostication. This study investigated the prognostic value of the alkaline phosphatase-to-albumin ratio (APAR) in mHSPC survival risk stratification.
Methods
We retrospectively analyzed 128 mHSPC patients. A cut-off of 2.92 for APAR was determined via ROC analysis. Overall survival (OS) was assessed using Kaplan–Meier methods and multivariable Cox regression adjusting for standard prognostic factors, including tumor volume and Gleason score.
Results
Patients with APAR ≥2.92 had significantly shorter OS compared to those with APAR
Zitieren
APA
Özalp, F. R., Arslan, A. M., Yetginoğlu, Ö., & Semiz, H. S. (2026). Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer. Journal of Basic and Clinical Health Sciences, 10(2), 222-228. https://doi.org/10.30621/jbachs.1834209
Vancouver
Özalp FR, Arslan AM, Yetginoğlu Ö, Semiz HS. Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer. Journal of Basic and Clinical Health Sciences. 2026;10(2):222-228. doi:10.30621/jbachs.1834209
BibTeX
@article{zalp2026,
author = {Özalp, Faruk Recep and Arslan, Ahmet Melih and Yetginoğlu, Özge and Semiz, Hüseyin Salih},
title = {Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer},
journal = {Journal of Basic and Clinical Health Sciences},
year = {2026},
volume = {10},
number = {2},
pages = {222--228},
doi = {10.30621/jbachs.1834209}
}
EUVIMED